Methylation‐mediated miR‐214 regulates proliferation and drug sensitivity of renal cell carcinoma cells through targeting LIVIN-Reference-Cited by-同舟云学术

Methylation‐mediated miR‐214 regulates proliferation and drug sensitivity of renal cell carcinoma cells through targeting LIVIN

Published:2020-05-12 Issue:11 Volume:24 Page:6410-6425
ISSN:1582-1838
Container-title:Journal of Cellular and Molecular Medicine
language:en
Short-container-title:J Cell Mol Med

Author:

Xu Hao¹,Wu Shangjun¹,Shen Xin²,Shi Zhan³,Wu Ding⁴,Yuan Yuan¹,Jiang Wei¹,Wang Qianliang¹,Ke Qin¹,Mao Qing¹,Li Xianlong¹,Liu Yong¹,Yuan Pingcheng¹,Zhang Qinghan¹,Huang Enying¹,Chen Xiaogang¹^ORCID

Affiliation:

1. Department of Urology Huangshi Central HospitalAffiliated Hospital of Hubei Polytechnic UniversityEdong Healthcare Group Huangshi China

2. Department of Abdominal and Pelvic Medical Oncology II Huangshi Central HospitalAffiliated Hospital of Hubei Polytechnic UniversityEdong Healthcare Group Huangshi China

3. The Comprehensive Cancer Centre of Drum Tower Hospital Medical School of Nanjing University & Clinical Cancer Institute of Nanjing University Nanjing China

4. Department of Urology Jinling HospitalNanjing Medical University Nanjing China

Funder

Natural Science Foundation of Hubei Province

Publisher

Wiley

Subject

Cell Biology,Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcmm.15287

Reference30 articles.

1. Renal cell carcinoma

2. Livin, a Novel Inhibitor of Apoptosis Protein Family Member